L-DOPA Ethyl Ester Hydrochloride

• CAT Number: R048047
• CAS Number: 39740-30-2
• Molecular Formula: C11H16ClNO4
• Molecular Weight: 261.702
• Purity: ≥95%
• Synonyms: L-Dopa Ethyl Ester Hydrochloride; Levodopa Ethyl Ester Hydrochloride; O-Ethyl-DOPA Hydrochloride; 3,4-Dihydroxy-L-phenylalanine Ethyl Ester Hydrochloride; 3-Hydroxy-L-tyrosine Ethyl Ester Hydrochloride
• Target: Neuronal Signaling
• Storage: Store at -20°C
• IUPAC Name: ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate;hydrochloride
• InChI: InChI=1S/C11H15NO4.ClH/c1-2-16-11(15)8(12)5-7-3-4-9(13)10(14)6-7;/h3-4,6,8,13-14H,2,5,12H2,1H3;1H/t8-;/m0./s1
• InChIKey: CVQFXVIIFKVRCK-QRPNPIFTSA-N
• SMILES: CCOC(=O)C(CC1=CC(=C(C=C1)O)O)N.Cl

L-DOPA Ethyl Ester Hydrochloride is a derivative of L-DOPA, an important precursor to dopamine, primarily used in the treatment of Parkinson’s disease. The ethyl ester modification enhances the compound’s lipophilicity, improving its absorption and bioavailability compared to L-DOPA. Once in the body, the ethyl ester is hydrolyzed, releasing L-DOPA, which crosses the blood-brain barrier and is converted into dopamine, helping to replenish low dopamine levels in patients with Parkinson’s. The hydrochloride salt form increases the compound’s stability and solubility, making it suitable for pharmaceutical formulations and research into dopamine-related disorders.